|
Based on the information provided, it could not be determined when the foreign material alleged to be v.A.C.® granufoam¿ dressing was placed in the wound.The foreign material was not returned for identification; therefore, solventum is unable to confirm its identity.All end release testing of the product and packaging met specifications.Device labeling, available online and in print, states: dressing changes wounds being treated with the v.A.C.® therapy system should be monitored on a regular basis.In a monitored, non-infected wound, v.A.C.® dressings should be changed every 48-72 hours, but no less than 3 times a week, with frequency adjusted by the clinician as appropriate.Infected wounds must be monitored often and very closely.For these wounds, dressings may need to be changed more often than 48-72 hours; the dressing changing intervals should be based on a continuing evaluation of the wound condition and the patient's clinical presentation, rather than a fixed schedule.Foam placement: always use v.A.C.® dressings from sterile packages that have not been opened or damaged.Do not place any foam dressing into blind / unexplored tunnels.The v.A.C.® whitefoam¿ dressing may be more appropriate for use with explored tunnels.Do not force foam dressings into any area of the wound, as this may damage tissue, alter the delivery of negative pressure or hinder exudate and foam removal.Always count the total number of pieces of foam used in the wound.Document the foam quantity and dressing change date on the drape or foam quantity label if available, and in the patient's chart.V.A.C.® dressing foam (except v.A.C.® granufoam silver¿ dressing) is radiolucent, not detectable on x-ray.Foam removal: v.A.C.® foam dressings are not bioabsorbable.Always count the total number of pieces of foam removed from the wound and ensure the same number of foam pieces are removed as were placed.Foam left in the wound for greater that the recommended time period may foster ingrowth of tissue into the foam, create difficulty in removing the foam from the wound or lead to infection or other adverse events.If dressing adheres to wound consider introducing sterile water or normal saline into the dressing, waiting 15 - 30 minutes, then gently removing the dressing from the wound.Regardless of treatment modality, disruption of the new granulation tissue during any dressing change may result in bleeding at the wound site.Minor bleeding may be observed and considered expected.However, patients with increased risk of bleeding, as described in the bleeding section, have a potential for more serious bleeding from the wound site.As a precautionary step, consider using v.A.C.® whitefoam¿ dressings or nonadherent material underneath the v.A.C.® granufoam¿ dressings to help minimize the potential for bleeding at dressing removal in these patients.Disclaimer: this information is submitted pursuant to 21 cfr 803, in compliance with the medical device reporting requirement and should not be considered to be an admission that a kinetic concepts, inc.Product malfunctioned, is defective or has caused serious injury.
|
|
On 24-apr-2025, the following information was provided by the nurse: a patient allegedly had small bits of black foam embedded in the wound.This makes a total of three patients now; some with as many as 75 pieces of black foam.There was some material present coming from the small v.A.C.® granufoam¿ dressing out of the package.On 29-apr-2025, the following information was provided by the nurse: the most recent patient had v.A.C.® granufoam¿ dressing placed, lot number c12078v011.The previous two patients were transferred from another acute care facility with embedded v.A.C.® granufoam¿ dressing so there are no lot numbers available.All three patients required sharp and mechanical debridement to remove the embedded foam.The exact dates of occurrence of the two previous patients were unknown.On 30-apr-2025, a device history record review was completed for v.A.C.® granufoam¿ dressing lot number c12078v011.All end release testing of product and packaging met specifications.The alleged patient with embedded small v.A.C.® granufoam¿ dressing for lot number c12078v011 is reported under mdr-3009897021-2025-00018.The alleged previous two patients with embedded v.A.C.® granufoam¿ dressing is reported under mdr-3009897021-2025-00019.
|